North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

Press releases published on November 11, 2026

9 hours ago

Applied Biologics Announces Research Collaboration with Dartmouth College Focused on Computational Protein Engineering

Indeterminate GlobeNewswire

9 hours ago

AC Immune to Present at Jefferies Global Healthcare Conference 2026

Indeterminate GlobeNewswire

9 hours ago

Horizon Europe-funded HERMOD project launches to support Phase 2 development of HER-096 in Parkinson’s disease

Indeterminate GlobeNewswire

9 hours ago

CHARM Therapeutics and Collaborator Dr. Florian Perner to Present Compelling Data Showing the Potential of Next-Generation Menin Inhibitors to Deliver More Durable Responses for AML at the 8th ASH Annual Meeting

Indeterminate GlobeNewswire

9 hours ago

Arvinas to Present at Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

9 hours ago

NRx Pharmaceuticals Begins Selling U.S.-Made, Preservative-Free Ketamine Amid Long-Running Shortage

Indeterminate GlobeNewswire

9 hours ago

Nurix Therapeutics Appoints Arati V. Rao, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

9 hours ago

Hemab Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

9 hours ago

Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club

Indeterminate GlobeNewswire

9 hours ago

Sinaptica Therapeutics to Host Scientific Symposium at CTAD 2026 Exploring the Role of Brain Network Dysfunction in Alzheimer's Disease

Indeterminate GlobeNewswire

9 hours ago

Nkarta Presents Initial Safety Data for NKX019 in 40 Patients Across Five Autoimmune Diseases at ACR Convergence 2026

Indeterminate GlobeNewswire

9 hours ago

CDT Commences Human Skin Studies with QIMA Life Sciences on Novel Tapinarof Combinations in Vitiligo

Indeterminate GlobeNewswire

10 hours ago

The savings that cost more: new report puts a number on Europe's innovation choice

Indeterminate GlobeNewswire

10 hours ago

64% of NMN Supplements Failed Independent Purity Testing: Element 5 Publishes Every Batch Report for Its Own

Indeterminate GlobeNewswire

12 hours ago

New Kidney International Study Provides Preclinical Proof-of-Concept for TolerogenixX’s MIC Platform in Lupus Nephritis

Indeterminate GlobeNewswire

14 hours ago

Devia Emerges from Stealth with an Agentic AI for GxP Pharma Quality Management

Indeterminate GlobeNewswire

17 hours ago

Onco-Innovations Announces Agreement to Terminate Performance-Based Funding Arrangement with Sorbie

Indeterminate GlobeNewswire

17 hours ago

Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock

Indeterminate GlobeNewswire

18 hours ago

Prime Medicine Announces Pricing of Public Offering of Common Stock

Indeterminate GlobeNewswire

Nov. 11, 2026

AGCバイオロジクス、チャイルズ・キュア・ジネティック・リサーチと提携し、重度のてんかん性疾患に対するmRNAベースの治療薬の開発に取り組む

Indeterminate GlobeNewswire